SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Eurofarma Board Approves Third-Quarter 2026 Results

Eurofarma Board Approves Third-Quarter 2026 Results Eurofarma Laboratórios’ board met on Nov. 13

Related stories